FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 341:1127-1133 October 7, 1999 Number 15 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF Purchase this article Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

In the not-so-distant past, type 2 diabetes mellitus was thought to be a relatively benign condition, at least in the elderly, with relatively little effect on life expectancy or renal function.¹ It has now become obvious that type 2 diabetes must be taken every bit as seriously as type 1 diabetes, in part because of its renal complications.² However, some recent and encouraging evidence indicates that diabetic nephropathy and deterioration of renal function are to a certain extent preventable.

Epidemiology

According to the reports of the U.S. Renal Data System,^3,4 in the past two decades there has been a continual increase . . . [Full Text of this Article]

Renal Lesions

Genetic Basis

Risk Factors

Glycemia

Smoking

Protein Intake

Blood Pressure

Renal Failure

Source Information

From the Department of Internal Medicine, Renal Unit, Ruperto Carola University, Bergheimer Str. 56a, D-69115 Heidelberg, Germany, where reprint requests should be addressed to Dr. Ritz.

References

Related Letters:

Nephropathy in Type 2 Diabetes
Mora C., Garcia J., Navarro J. F., Vandor T., Grace D. M., Ritz E., Orth S.
Extract | Full Text  
N Engl J Med 2000; 342:441-442, Feb 10, 2000. Correspondence

This article has been cited by other articles:

• Wolf, G., Muller, N., Busch, M., Eidner, G., Kloos, C., Hunger-Battefeld, W., Muller, U. A (2009). Diabetic foot syndrome and renal function in type 1 and 2 diabetes mellitus show close association. Nephrol Dial Transplant 24: 1896-1901 [Abstract] [Full Text]  
• Ravera, M., Noberasco, G., Re, M., Filippi, A., Gallina, A. M., Weiss, U., Cannavo, R., Ravera, G., Cricelli, C., Deferrari, G. (2009). Chronic kidney disease and cardiovascular risk in hypertensive type 2 diabetics: a primary care perspective. Nephrol Dial Transplant 24: 1528-1533 [Abstract] [Full Text]  
• Dreyer, G., Hull, S., Aitken, Z., Chesser, A., Yaqoob, M.M. (2009). The effect of ethnicity on the prevalence of diabetes and associated chronic kidney disease. QJM 102: 261-269 [Abstract] [Full Text]  
• de Galan, B. E., Perkovic, V., Ninomiya, T., Pillai, A., Patel, A., Cass, A., Neal, B., Poulter, N., Harrap, S., Mogensen, C.-E., Cooper, M., Marre, M., Williams, B., Hamet, P., Mancia, G., Woodward, M., Glasziou, P., Grobbee, D. E., MacMahon, S., Chalmers, J., on behalf of the ADVANCE Collaborative Group, (2009). Lowering Blood Pressure Reduces Renal Events in Type 2 Diabetes. J. Am. Soc. Nephrol. 20: 883-892 [Abstract] [Full Text]  
• Wright, J., Vardhan, A. (2008). Review: The problem of diabetic nephropathy and practical prevention of its progression. British Journal of Diabetes & Vascular Disease 8: 272-277 [Abstract]  
• Zdychova, J., Kazdova, L., Pelikanova, T., Lindsley, J. N., Anderson, S., Komers, R. (2008). Renal Activity of Akt Kinase in Obese Zucker Rats. Exp. Biol. Med. 233: 1231-1241 [Abstract] [Full Text]  
• Izuhara, Y., Sada, T., Yanagisawa, H., Koike, H., Ohtomo, S., Dan, T., Ito, S., Nangaku, M., van Ypersele de Strihou, C., Miyata, T. (2008). A Novel Sartan Derivative With Very Low Angiotensin II Type 1 Receptor Affinity Protects the Kidney in Type 2 Diabetic Rats. Arterioscler. Thromb. Vasc. Bio. 28: 1767-1773 [Abstract] [Full Text]  
• Omori, K., Ohira, T., Uchida, Y., Ayilavarapu, S., Batista, E. L. Jr., Yagi, M., Iwata, T., Liu, H., Hasturk, H., Kantarci, A., Van Dyke, T. E. (2008). Priming of neutrophil oxidative burst in diabetes requires preassembly of the NADPH oxidase. J. Leukoc. Biol. 84: 292-301 [Abstract] [Full Text]  
• White, S. L., McGeechan, K., Jones, M., Cass, A., Chadban, S. J., Polkinghorne, K. R., Perkovic, V., Roderick, P. J. (2008). Socioeconomic Disadvantage and Kidney Disease in the United States, Australia, and Thailand. AJPH 98: 1306-1313 [Abstract] [Full Text]  
• Kattla, J. J., Carew, R. M., Heljic, M., Godson, C., Brazil, D. P. (2008). Protein kinase B/Akt activity is involved in renal TGF-{beta}1-driven epithelial-mesenchymal transition in vitro and in vivo. Am. J. Physiol. Renal Physiol. 295: F215-F225 [Abstract] [Full Text]  
• Obermayr, R. P., Temml, C., Knechtelsdorfer, M., Gutjahr, G., Kletzmayr, J., Heiss, S., Ponholzer, A., Madersbacher, S., Oberbauer, R., Klauser-Braun, R. (2008). Predictors of new-onset decline in kidney function in a general middle-european population. Nephrol Dial Transplant 23: 1265-1273 [Abstract] [Full Text]  
• Kelly, C. J., Booth, G. (2008). Pharmacist-led structured care for patients with diabetic nephropathy. British Journal of Diabetes & Vascular Disease 8: 86-88 [Abstract]  
• Ohno, T., Takamoto, S., Motomura, N. (2008). Diabetic Retinopathy and Coronary Artery Disease From the Cardiac Surgeon's Perspective. Ann. Thorac. Surg. 85: 681-689 [Abstract] [Full Text]  
• Sloan, F. A., Bethel, M. A., Ruiz, D. Jr, Shea, A. H., Feinglos, M. N. (2008). The Growing Burden of Diabetes Mellitus in the US Elderly Population. Arch Intern Med 168: 192-199 [Abstract] [Full Text]  
• Yee, J. (2008). Diabetic Kidney Disease: Chronic Kidney Disease and Diabetes. Diabetes Spectr. 21: 8-10 [Full Text]  
• Odden, M. C., Scherzer, R., Bacchetti, P., Szczech, L. A., Sidney, S., Grunfeld, C., Shlipak, M. G. (2007). Cystatin C Level as a Marker of Kidney Function in Human Immunodeficiency Virus Infection: The FRAM Study. Arch Intern Med 167: 2213-2219 [Abstract] [Full Text]  
• Tentolouris, N., Nzietchueng, R., Cattan, V., Poitevin, G., Lacolley, P., Papazafiropoulou, A., Perrea, D., Katsilambros, N., Benetos, A. (2007). White Blood Cells Telomere Length Is Shorter in Males With Type 2 Diabetes and Microalbuminuria. Diabetes Care 30: 2909-2915 [Abstract] [Full Text]  
• Griffin, K. A., Abu-Naser, M., Abu-Amarah, I., Picken, M., Williamson, G. A., Bidani, A. K. (2007). Dynamic blood pressure load and nephropathy in the ZSF1 (fa/facp) model of type 2 diabetes. Am. J. Physiol. Renal Physiol. 293: F1605-F1613 [Abstract] [Full Text]  
• Bavbek, N., Kargili, A., Kaftan, O., Karakurt, F., Kosar, A., Akcay, A. (2007). Elevated Concentrations of Soluble Adhesion Molecules and Large Platelets in Diabetic Patients: Are They Markers of Vascular Disease and Diabetic Nephropathy?. CLIN APPL THROMB HEMOST 13: 391-397 [Abstract]  
• Maahs, D. M., Snively, B. M., Bell, R. A., Dolan, L., Hirsch, I., Imperatore, G., Linder, B., Marcovina, S. M., Mayer-Davis, E. J., Pettitt, D. J., Rodriguez, B. L., Dabelea, D. (2007). Higher Prevalence of Elevated Albumin Excretion in Youth With Type 2 Than Type 1 Diabetes: The SEARCH for Diabetes in Youth Study. Diabetes Care 30: 2593-2598 [Abstract] [Full Text]  
• Elsayed, E. F., Tighiouart, H., Griffith, J., Kurth, T., Levey, A. S., Salem, D., Sarnak, M. J., Weiner, D. E. (2007). Cardiovascular Disease and Subsequent Kidney Disease. Arch Intern Med 167: 1130-1136 [Abstract] [Full Text]  
• Rosenthal, T., Rosenmann, E., Tomassoni, D., Amenta, F. (2007). Effect of Lercanidipine on Kidney Microanatomy in Cohen-Rosenthal Diabetic Hypertensive Rats. J CARDIOVASC PHARMACOL THER 12: 145-152 [Abstract]  
• Holt, R. M., Schwartz, F. L., Shubrook, J. H. (2007). Diabetes Care in Extended-Care Facilities: Appropriate intensity of care?. Diabetes Care 30: 1454-1458 [Abstract] [Full Text]  
• Lin, H.-Y., Wang, C.-L., Hsiao, P.-J., Lu, Y.-C., Chen, S.-Y., Lin, K.-D., Hsin, S.-C., Hsieh, M.-C., Shin, S.-J. (2007). SUMO4 M55V Variant Is Associated With Diabetic Nephropathy in Type 2 Diabetes. Diabetes 56: 1177-1180 [Abstract] [Full Text]  
• Lee, S., Kim, W., Moon, S.-O., Sung, M. J., Kim, D. H., Kang, K. P., Jang, K. Y., Lee, S. Y., Park, B. H., Koh, G. Y., Park, S. K. (2007). Renoprotective effect of COMP-angiopoietin-1 in db/db mice with type 2 diabetes. Nephrol Dial Transplant 22: 396-408 [Abstract] [Full Text]  
• Hartner, A., Cordasic, N., Klanke, B., Wittmann, M., Veelken, R., Hilgers, K. F. (2007). Renal injury in streptozotocin-diabetic Ren2-transgenic rats is mainly dependent on hypertension, not on diabetes. Am. J. Physiol. Renal Physiol. 292: F820-F827 [Abstract] [Full Text]  
• Koopman, R. J., Mainous, A. G. III, Liszka, H. A., Colwell, J. A., Slate, E. H., Carnemolla, M. A., Everett, C. J. (2006). Evidence of Nephropathy and Peripheral Neuropathy in US Adults With Undiagnosed Diabetes.. Ann Fam Med 4: 427-432 [Abstract] [Full Text]  
• Mann, J. F. E., McClellan, W. M., Kunz, R., Ritz, E. (2006). Progression of renal disease--can we forget about inhibition of the renin-angiotensin system?. Nephrol Dial Transplant 21: 2348-2351 [Full Text]  
• Retnakaran, R., Cull, C. A., Thorne, K. I., Adler, A. I., Holman, R. R., for the UKPDS Study Group, (2006). Risk Factors for Renal Dysfunction in Type 2 Diabetes: U.K. Prospective Diabetes Study 74. Diabetes 55: 1832-1839 [Abstract] [Full Text]  
• Moran, A., Palmas, W., Pickering, T. G., Schwartz, J. E., Field, L., Weinstock, R. S., Shea, S. (2006). Office and Ambulatory Blood Pressure Are Independently Associated With Albuminuria in Older Subjects With Type 2 Diabetes. Hypertension 47: 955-961 [Abstract] [Full Text]  
• Remuzzi, G., Macia, M., Ruggenenti, P. (2006). Prevention and Treatment of Diabetic Renal Disease in Type 2 Diabetes: The BENEDICT Study. J. Am. Soc. Nephrol. 17: S90-S97 [Abstract] [Full Text]  
• Asbun, J., Villarreal, F. J. (2006). The Pathogenesis of Myocardial Fibrosis in the Setting of Diabetic Cardiomyopathy. J Am Coll Cardiol 47: 693-700 [Abstract] [Full Text]  
• Inagi, R., Yamamoto, Y., Nangaku, M., Usuda, N., Okamato, H., Kurokawa, K., van Ypersele de Strihou, C., Yamamoto, H., Miyata, T. (2006). A Severe Diabetic Nephropathy Model With Early Development of Nodule-Like Lesions Induced by Megsin Overexpression in RAGE/iNOS Transgenic Mice. Diabetes 55: 356-366 [Abstract] [Full Text]  
• Nangaku, M., Izuhara, Y., Usuda, N., Inagi, R., Shibata, T., Sugiyama, S., Kurokawa, K., van Ypersele de Strihou, C., Miyata, T. (2005). In a type 2 diabetic nephropathy rat model, the improvement of obesity by a low calorie diet reduces oxidative/carbonyl stress and prevents diabetic nephropathy. Nephrol Dial Transplant 20: 2661-2669 [Abstract] [Full Text]  
• Izuhara, Y., Nangaku, M., Inagi, R., Tominaga, N., Aizawa, T., Kurokawa, K., van Ypersele de Strihou, C., Miyata, T. (2005). Renoprotective Properties of Angiotensin Receptor Blockers beyond Blood Pressure Lowering. J. Am. Soc. Nephrol. 16: 3631-3641 [Abstract] [Full Text]  
• Strippoli, G. F.M., Craig, M., Schena, F. P., Craig, J. C. (2005). Antihypertensive Agents for Primary Prevention of Diabetic Nephropathy. J. Am. Soc. Nephrol. 16: 3081-3091 [Abstract] [Full Text]  
• Song, K.-H., Ko, S. H., Kim, H.-W., Ahn, Y.-B., Lee, J.-M., Son, H.-S., Yoon, K.-H., Cha, B.-Y., Lee, K.-W., Son, H.-Y. (2005). Prospective Study of Lipoprotein(a) as a Risk Factor for Deteriorating Renal Function in Type 2 Diabetic Patients With Overt Proteinuria. Diabetes Care 28: 1718-1723 [Abstract] [Full Text]  
• Rigalleau, V., Lasseur, C., Perlemoine, C., Barthe, N., Raffaitin, C., Liu, C., Chauveau, P., Baillet-Blanco, L., Beauvieux, M.-C., Combe, C., Gin, H. (2005). Estimation of Glomerular Filtration Rate in Diabetic Subjects: Cockcroft formula or Modification of Diet in Renal Disease study equation?. Diabetes Care 28: 838-843 [Abstract] [Full Text]  
• Hilgers, K. F., Veelken, R. (2005). Type 2 Diabetic Nephropathy: Never too Early to Treat?. J. Am. Soc. Nephrol. 16: 574-575 [Full Text]  
• Wasen, E., Isoaho, R., Mattila, K., Vahlberg, T., Kivela, S.-L., Irjala, K. (2004). Renal Impairment Associated With Diabetes in the Elderly. Diabetes Care 27: 2648-2653 [Abstract] [Full Text]  
• Zhao, H.-L., Tong, P. C.Y., Lai, F. M.M., Tomlinson, B., Chan, J. C.N. (2004). Association of Glomerulopathy With the 5'-End Polymorphism of the Aldose Reductase Gene and Renal Insufficiency in Type 2 Diabetic Patients. Diabetes 53: 2984-2991 [Abstract] [Full Text]  
• Strippoli, G. F M, Craig, M., Deeks, J. J, Schena, F. P., Craig, J. C (2004). Effects of angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists on mortality and renal outcomes in diabetic nephropathy: systematic review. BMJ 329: 828- [Abstract] [Full Text]  
• Meier, J. J., Nauck, M. A., Kranz, D., Holst, J. J., Deacon, C. F., Gaeckler, D., Schmidt, W. E., Gallwitz, B. (2004). Secretion, Degradation, and Elimination of Glucagon-Like Peptide 1 and Gastric Inhibitory Polypeptide in Patients with Chronic Renal Insufficiency and Healthy Control Subjects. Diabetes 53: 654-662 [Abstract] [Full Text]  
• Omori, K., Naruishi, K., Nishimura, F., Yamada-Naruishi, H., Takashiba, S. (2004). High Glucose Enhances Interleukin-6-induced Vascular Endothelial Growth Factor 165 Expression via Activation of Gp130-mediated p44/42 MAPK-CCAAT/Enhancer Binding Protein Signaling in Gingival Fibroblasts. J. Biol. Chem. 279: 6643-6649 [Abstract] [Full Text]  
• Wong, T. Y., Shankar, A., Klein, R., Klein, B. E.K. (2004). Retinal Vessel Diameters and the Incidence of Gross Proteinuria and Renal Insufficiency in People With Type 1 Diabetes. Diabetes 53: 179-184 [Abstract] [Full Text]  
• Gahagan, S., Silverstein, J., Committee on Native American Child Health, , Section on Endocrinology, (2003). Prevention and Treatment of Type 2 Diabetes Mellitus in Children, With Special Emphasis on American Indian and Alaska Native Children. Pediatrics 112: e328-e328 [Abstract] [Full Text]  
• Amann, B., Tinzmann, R., Angelkort, B. (2003). ACE Inhibitors Improve Diabetic Nephropathy Through Suppression of Renal MCP-1. Diabetes Care 26: 2421-2425 [Abstract] [Full Text]  
• Susztak, K., Sharma, K., Schiffer, M., McCue, P., Ciccone, E., Bottinger, E. P. (2003). Genomic Strategies for Diabetic Nephropathy. J. Am. Soc. Nephrol. 14: S271-278 [Abstract] [Full Text]  
• Kramer, H. J., Nguyen, Q. D., Curhan, G., Hsu, C.-y. (2003). Renal Insufficiency in the Absence of Albuminuria and Retinopathy Among Adults With Type 2 Diabetes Mellitus. JAMA 289: 3273-3277 [Abstract] [Full Text]  
• Konner, K., Nonnast-Daniel, B., Ritz, E. (2003). The Arteriovenous Fistula. J. Am. Soc. Nephrol. 14: 1669-1680 [Full Text]  
• Ueda, H., Ishimura, E., Shoji, T., Emoto, M., Morioka, T., Matsumoto, N., Fukumoto, S., Miki, T., Inaba, M., Nishizawa, Y. (2003). Factors Affecting Progression of Renal Failure in Patients With Type 2 Diabetes. Diabetes Care 26: 1530-1534 [Abstract] [Full Text]  
• Nangaku, M., Miyata, T., Sada, T., Mizuno, M., Inagi, R., Ueda, Y., Ishikawa, N., Yuzawa, H., Koike, H., van Ypersele de Strihou, C., Kurokawa, K. (2003). Anti-Hypertensive Agents Inhibit In Vivo the Formation of Advanced Glycation End Products and Improve Renal Damage in a Type 2 Diabetic Nephropathy Rat Model. J. Am. Soc. Nephrol. 14: 1212-1222 [Abstract] [Full Text]  
• Mason, R. M., Wahab, N. A. (2003). Extracellular Matrix Metabolism in Diabetic Nephropathy. J. Am. Soc. Nephrol. 14: 1358-1373 [Abstract] [Full Text]  
• Mogensen, C. E., Viberti, G., Halimi, S., Ritz, E., Ruilope, L., Jermendy, G., Widimsky, J., Sareli, P., Taton, J., Rull, J., Erdogan, G., De Leeuw, P. W., Ribeiro, A., Sanchez, R., Mechmeche, R., Nolan, J., Sirotiakova, J., Hamani, A., Scheen, A., Hess, B., Luger, A., Thomas, S. M. (2003). Effect of Low-Dose Perindopril/Indapamide on Albuminuria in Diabetes: Preterax in Albuminuria Regression: PREMIER. Hypertension 41: 1063-1071 [Abstract] [Full Text]  
• Sheetz, M. J., King, G. L. (2002). Molecular Understanding of Hyperglycemia's Adverse Effects for Diabetic Complications. JAMA 288: 2579-2588 [Abstract] [Full Text]  
• Lurbe, E., Redon, J., Kesani, A., Pascual, J. M., Tacons, J., Alvarez, V., Batlle, D. (2002). Increase in Nocturnal Blood Pressure and Progression to Microalbuminuria in Type 1 Diabetes. NEJM 347: 797-805 [Abstract] [Full Text]  
• Makino, H., Tanaka, I., Mukoyama, M., Sugawara, A., Mori, K., Muro, S., Suganami, T., Yahata, K., Ishibashi, R., Ohuchida, S., Maruyama, T., Narumiya, S., Nakao, K. (2002). Prevention of Diabetic Nephropathy in Rats by Prostaglandin E Receptor EP1-Selective Antagonist. J. Am. Soc. Nephrol. 13: 1757-1765 [Abstract] [Full Text]  
• Gambaro, G., Kinalska, I., Oksa, A., Pont'uch, P., Hertlova, M., Olsovsky, J., Manitius, J., Fedele, D., Czekalski, S., Perusicova, J., Skrha, J., Taton, J., Grzeszczak, W., Crepaldi, G. (2002). Oral Sulodexide Reduces Albuminuria in Microalbuminuric and Macroalbuminuric Type 1 and Type 2 Diabetic Patients: The Di.N.A.S. Randomized Trial. J. Am. Soc. Nephrol. 13: 1615-1625 [Abstract] [Full Text]  
• Remuzzi, G., Schieppati, A., Ruggenenti, P. (2002). Nephropathy in Patients with Type 2 Diabetes. NEJM 346: 1145-1151 [Full Text]  
• Hilgers, K. F., Mann, J. F. E. (2002). ACE Inhibitors versus AT1 Receptor Antagonists in Patients with Chronic Renal Disease. J. Am. Soc. Nephrol. 13: 1100-1108 [Full Text]  
• Bilous, R. W (2002). Angiotensin II receptor blockade and type 2 diabetic nephropathy. British Journal of Diabetes & Vascular Disease 2: 101-105 [Abstract]  
• Hostetter, T. H. (2001). Prevention of End-Stage Renal Disease Due to Type 2 Diabetes. NEJM 345: 910-912 [Full Text]  
• Tabaei, B. P., Al-Kassab, A. S., Ilag, L. L., Zawacki, C. M., Herman, W. H. (2001). Does Microalbuminuria Predict Diabetic Nephropathy?. Diabetes Care 24: 1560-1566 [Abstract] [Full Text]  
• Cooper, D. S., DeAngelis, C. D. (2001). Diabetes Mellitus--A Call for Papers. JAMA 286: 968-969 [Full Text]  
• Schindler, R., Radke, C., Paul, K., Frei, U. (2001). Renal problems after lung transplantation of cystic fibrosis patients. Nephrol Dial Transplant 16: 1324-1328 [Full Text]  
• Geerlings, S. E., Stolk, R. P., Camps, M. J. L., Netten, P. M., Collet, J. T., Schneeberger, P. M., Hoepelman, A. I. M. (2001). Consequences of Asymptomatic Bacteriuria in Women With Diabetes Mellitus. Arch Intern Med 161: 1421-1427 [Abstract] [Full Text]  
• STROJEK, K., GRZESZCZAK, W., GÓRSKA, J., LESCHINGER, M. I., RITZ, E. (2001). Lowering of Microalbuminuria in Diabetic Patients by a Sympathicoplegic Agent: Novel Approach to Prevent Progression of Diabetic Nephropathy?. J. Am. Soc. Nephrol. 12: 602-605 [Abstract] [Full Text]  
• Olefsky, J. M. (2001). Prospects for Research in Diabetes Mellitus. JAMA 285: 628-632 [Abstract] [Full Text]  
• Cheng, Z. J., Vaskonen, T., Tikkanen, I., Nurminen, K., Ruskoaho, H., Vapaatalo, H., Muller, D., Park, J.-K., Luft, F. C., Mervaala, E. M. A. (2001). Endothelial Dysfunction and Salt-Sensitive Hypertension in Spontaneously Diabetic Goto-Kakizaki Rats. Hypertension 37: 433-439 [Abstract] [Full Text]  
• Ruggenenti, P., Remuzzi, G. (2000). Nephropathy of type 1 and type 2 diabetes: diverse pathophysiology, same treatment?. Nephrol Dial Transplant 15: 1900-1902 [Full Text]  
• Siffert, W. (2000). G protein {beta}3 subunit 825T allele, hypertension, obesity, and diabetic nephropathy. Nephrol Dial Transplant 15: 1298-1306 [Abstract] [Full Text]  
• Weinberg, M. S, Weinberg, A. J, Zappe, D. H (2000). Effectively targetting the renin-angiotensin-aldosterone system in cardiovascular and renal disease: rationale for using angiotensin II receptor blockers in combination with angiotensin-converting enzyme inhibitors. Journal of Renin-Angiotensin-Aldosterone System 1: 217-233  
• Mora, C., Garcia, J., Navarro, J. F., Vandor, T., Grace, D. M., Ritz, E., Orth, S. (2000). Nephropathy in Type 2 Diabetes. NEJM 342: 441-442 [Full Text]